Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From Shionogi & Co. Ltd.

Finance Watch: Investors Remain Receptive To Biopharma, Health Care SPAC IPOs

Public Company Edition: 2020 started with two $200m-plus initial public offerings plus five health care-focused special purpose acquisition corporations IPOs. Also, a Pfizer initiative backs three public companies, Fate’s $432m offering led recent FOPOs and Biocon Biologics receives more investment. 

Financing Business Strategies

2020 Sees Sharp Rise In EU New Drug Approvals

The number of new drugs containing new active substances approved in the EU rose significantly in 2020, underpinned by a strong showing for orphan-designated products and a string of novel medicines for cancer and infectious diseases. Notable among the new clutch of approvals was the first ever COVID-19 vaccine, Pfizer/BioNTech's Comirnaty.

Europe Approvals

COVID-19 Could Change Attitudes To Flu, Bolster Xofluza

Roche’s first-in-class one-dose antiviral Xofluza has been approved for marketing in the EU to treat influenza in patients aged 12 years or over, and for post-exposure prophylaxis.

Infectious Diseases Approvals

Pharma Power Japan Barely In COVID Vaccines Race. Why?

Despite having multiple world-class pharma companies and innovative research, Japan is notably absent as a source of candidate vaccines for the coronavirus. The pandemic is again throwing into sharp relief past and present challenges around the country's vaccines sector.

Japan Coronavirus COVID-19
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Shionogi Healthcare Co., Ltd
    • Shionogi Pharma Co., Ltd
    • Shionogi Techno Advance Research Co., Ltd.
    • Shionogi Administration Service Co., Ltd.
    • Shionogi Business Partner Co., Ltd
    • Shionogi Marketing Solutions Co., Ltd
    • Shionogi Career Development Center Co., Ltd.
    • Shionogi Digital Science Co., Ltd.
    • Shionogi Pharmacovigilance Center Co., Ltd.
    • Aburahi AgroResearch Co., Ltd.
    • Shionogi Smile Heart Co., Ltd
    • UMN Pharma Inc.
    • etc.
UsernamePublicRestriction

Register